Induction of whole body hyperthemia with venovenous perfusion

ASAIO Journal

Volumn 42, Issue 4, 1996, Pages 250-254

  Vertrees, Roger A ^a   Tao, Weike ^a   Pencil, Scot D ^a   Sites, Jeffery P ^b   Althoff, Donald P ^b   Zwischenberger, Joseph B ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b IP Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; COMPUTER CONTROL SYSTEMS; DATA ACQUISITION; HEAT TRANSFER; MONITORING; ONCOLOGY; TEMPERATURE; TEMPERATURE DISTRIBUTION; THERMAL GRADIENTS; TISSUE; VIRUSES;

HEAT EXCHANGE SYSTEM; HEAT INDUCTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS; VENOVENOUS PERFUSION;

HYPERTHERMIA THERAPY;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; BONE MARROW; CORE TEMPERATURE; HEAT EXCHANGE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHERMIC THERAPY; METASTASIS; NONHUMAN; SWINE;

ANIMALS; BODY TEMPERATURE; FEVER; HIV INFECTIONS; NEOPLASMS; PERFUSION; SWINE;

EID: 0030200844     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199607000-00004     Document Type: Article

References (14)

1. Parks LC, Minaberry D, Smith DP, Neely WA: Treatment of far-advanced bronchogenic carcinoma by extracorporeally induced systemic hyperthermia. J Thorac Cardiovasc Surg 78: 883-892, 1979.
2. Gabriele P, Orecchia R, Ragona R, Tseroni V, Sannazzari GL: Hyperthermia alone in the treatment of recurrences of malignant tumors: experience with 60 lesions. Cancer 66: 2191-2195, 1990.
3. Groom RC, Hill AG: Hyperthermic cancer treatment: systemic hyperthermia and isolated limb perfusion. Proc Am Acad Cardiovasc Perfusion 8: 105-111, 1987.
4. Frazier OH: The use of hyperthermia in the treatment of cancer. Proc Am Acad Cardiovasc Perfusion 3: 99-104, 1982.
5. Alonso K, Pontiggia P, Nardi C, Sabato A, Cuppone Curto F: Systemic hyperthermia in the treatment of HIV-related Kaposi's sarcoma: a phase I study. Biomed Pharmacother 46: 21-24, 1992.
6. Logan WD Jr, Alonso K: Total body hyperthermia in the treatment of Kaposi's sarcoma in an HIV positive patient. Med Oncol Tumor Pharmacother 8: 45-47, 1991.
7. Pettigrew RT, Galt JM, Ludgate CM, Smith AN: Clinical effects of whole-body hyperthermia in advanced malignancy. Br Med J 4: 679-682, 1974.
8. Bull JM, Lees D, Schuette W, et al: Whole body hyperthermia: a phase-1 trial of a potential adjuvant to chemotherapy. Ann Intern Med 90: 317-323, 1979.
9. Bartlett RH, McEwen D, Haiduc N, Roohk HV: Hypoxic hyperthermia induced by extracorporeal circulation: a preliminary report. ASAIO Trans 26: 530-532, 1980.
10. Herman TS, Zukoski CF, Anderson RM, et al: Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies. Cancer Treat Rep 66: 259-265, 1982.
11. Anderson HL III, Snedecor SM, Otsu T, Bartlett RH: Multicenter comparison of conventional venoarterial access versus venovenous double-lumen catheter access in newborn infants undergoing extracorporeal membrane oxygenation. J Pediatr Surg 28: 530-534, 1993.
12. National Academy of Science: Guide for the Care and Use of Laboratory Animals. Bethesda, MD, the National Institutes of Health (NIH publication No. 85-23, Revised 1985).
13. Matsumi N, Matsumoto K, Mishima N, et al: Thermal damage threshold of brain tissue: histological study of heated normal monkey brains. Neurol Med Chir (Tokyo) 34: 209-215, 1994.
14. Robins HI, Sielaff KM, Storer B, Hawkins MJ, Borden EC: Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer. Cancer Res 49: 1609-1615, 1989.